Transitioning Through ADHD: Pharmacotherapeutic Management from Childhood to Adulthood

Wednesday, December 5, 2012
2:00 PM – 4:00 PM

Activity #: 204-000-12-200-L01P
Level of Content: Intermediate
2.00 Contact Hours / Application-based
Program Chair: David G. Fuentes, PharmD, BCPP

Learning Objectives:

• Apply patient-specific adherence barriers and the co-morbidities to the selection of the most beneficial attention deficit hyperactivity disorder (ADHD) treatment options.
• Design a patient-specific treatment plan for the management of the presenting ADHD symptoms/chief complaint.
• Evaluate a patient's ADHD medication regimen customized to personal adherence practices, labs, and concurrent medical illnesses.
• Interpret population safety data to determine the use of the most optimal agents for the management of a health system's ADHD medication formulary.